Your search for major depressive disorder returned 6 results

This prospective, multi-center, open-label trial, CAN-BIND-1 was conducted between 2012 and 2017.

Cognitive behavioral therapy for insomnia (CBT-I) has an overall benefit in the prevention of incident and recurrent major depression in older adults with insomnia disorder.

Differences in sleep patterns, which can be objectively measured with wrist-worn accelerometers, are the norm among patients with lifetime psychiatric conditions.

According to a new poll, more than 90% of adults who reported they get good sleep were also free of depressive symptoms.

Previous studies have found that perinatal women have had detriments to sleep and depression during the pandemic; however, all studies to date in the perinatal setting have lacked a comparator group, so robust conclusions about the effect of the COVID-19 pandemic have not been elucidated.

Solriamfetol, a dopamine-norepinephrine reuptake inhibitor, improves excessive daytime sleepiness in OSA regardless of primary OSA therapy adherence.